Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company

Editorial photo #10462336 Economy, Business and Finance

Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company

An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03 September, 2023. (Photo by Jaap Arriens/NurPhoto)

Photo details

Photo ID
#10462336
Date taken
Location
—
Photographer
Jaap Arriens/NurPhoto
Category
Economy, Business and Finance
Copyright
© 2026 NurPhoto - Jaap Arriens/NurPhoto

Related keywords

Novo Nordisk Ozempic Poland Polska Rybelsus Semaglutide Warsaw Warszawa Wegovy antidiabetic brand branding diabetes care diabetes management diabetes medication diabetes support diabetes treatment editorial photography fat loss health healthcare healthcare advancements healthcare photography healthcare technology injection insulin medical equipment medical innovation medical procedure medication medication administration medicine needle needle injection patient treatment pen pharmaceutical pharmaceuticals subcutaneous injection Ozempic needle injection pen illustration Warsaw Poland 03 September 2023 Jaap Arriens/NurPhoto
Share
Rights-Managed (RM) · Single Editorial Use

License This Image

Configure usage rights. Price adjusts in real time.

One license covers one publication within the parameters you select. Each additional publication (e.g. separate articles, posts, issues) requires its own license. License terms ›

Media Type
Image Size
License Duration
Territory
Page Placement
Monthly Page Views
Print Run / Circulation
Your License Quote
Web & Digital / Small
1 Month · Single Country
€35.00
excl. VAT
or 35 credits
View price breakdown
Base price (3 months)€50.00
License total€35.00

Secure checkout via Stripe & PayPal

Need custom or commercial rights? Contact Sales · [email protected]

© 2026 NurPhoto. All rights reserved. This image is the property of NurPhoto and is protected under international copyright laws.

More like this

View all
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company
An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03...
Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company